Enerceptan

· Gema Biotech S.A.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Enerceptan, covering 2017-11-06 to 2018-01-23. Get the full timeline:

Most recent: Clinical Trial Update: Long Term Efficacy, Safety and Immunogenicity of Enerceptan in Rheumatoid Arthritis ( GEMENE002 ) [Phase 3]